Stock data
Bio-Rad Laboratories, Inc. (BIO)
Bio-Rad Laboratories, Inc. (BIO) reported revenue of US$2.58B and net income of US$759.90M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$2.58B | US$1.34B | US$47.20M | US$759.90M | — |
| 2024 | US$2.57B | US$1.38B | US$269.00M | -US$1.84B | — |
| 2023 | US$2.67B | US$1.43B | US$337.80M | -US$637.30M | — |
| 2022 | US$2.80B | US$1.57B | US$482.60M | -US$3.63B | — |
| 2021 | US$2.92B | US$1.64B | US$500.34M | US$4.25B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$651.00M | US$371.40M | — |
| 2026-03-31 | US$592.10M | -US$527.10M | — |
| 2025-12-31 | US$693.20M | US$720.00M | — |
| 2025-09-30 | US$653.00M | -US$341.90M | — |
| 2025-06-30 | US$651.60M | US$317.80M | — |
| 2025-03-31 | US$585.40M | US$64.00M | — |
| 2024-12-31 | US$667.50M | -US$715.80M | — |
| 2024-09-30 | US$649.70M | US$653.20M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.